Practice Areas

  • Corporate/M&A
  • Private Equity, Venture Capital
  • Joint Ventures
  • Corporate Litigation and Arbitration
Show moreShow less
Education and Professional Experience
  • Lawyer at GSK Stockmann since 2014
  • Employment and partner at major international law firms
  • Secondment to group legal department of KarstadtQuelle AG, headquarters in Essen
  • Admitted to practise law in Germany (2001)
  • Academic Assistant at the University of Augsburg
  • Universities of Würzburg and National University of Ireland, Galway
Languages
  • English, German, Italian
Memberships
  • Deutsche Institution für Schiedsgerichtsbarkeit (DIS) e.V. (German Institution of Arbitration)
Awards
  • Recommended lawyer in the field of “Corporate Law” and “Health” (The Legal 500 2022)
  • Recommended lawyer in the field of “Corporate Law” and “Health” (The Legal 500 2021)
Publications
  • Scherer/Söhnchen, in: Frankfurter Kommentar zum Kapitalanlagerecht, 2019, Band 3 (Recht der Assetklassen), Kapital 1 (Aktienfonds), S. 3 ff.
  • Söhnchen, Markus / Zentis, Sascha / Berka, Dominik / Eichler, Dr. Andreas / Huperz, Dr. Philip: Hot Topics bei Immobilientransaktionen, in: Betriebsberater 2018, S. 1090 ff.
  • Media review
    14 July 2022

    Public M&A Germany: GSK Stockmann contributed to the publication Lexology GTDT - M&A

    GSK Stockmann contributed to the Lexology GTDT publication: Andreas Bauer, Markus Söhnchen and Andreas Hainz composed the chapter "Public M&A (Germany)".

    Read more
  • Uncategorized
    15 June 2022

    GSK Stockmann advises the shareholders of ACTEUM Investment GmbH on the sale of the company to LBBW Immobilien, part of Landesbank Baden-Württemberg

    GSK Stockmann advised the previous shareholders and founders of ACTEUM Investment GmbH on the transaction and the M&A-relevant legal issues with a team led by Markus Söhnchen and G...

    Read more
  • Deal News
    04 February 2022

    GSK Stockmann advises aTmos Group shareholders on the sale of the group to Ufenau Capital Partners

    GSK Stockmann advised the current shareholders of the aTmos Group on the sale of the group to Ufenau Capital Partners.

    Read more
* Partner: a partner within the meaning of the German Partnership Companies Act.
   Local Partner: not a partner within the meaning of the German Partnership Companies Act.
CO2 Neutral